NCT05513092

Brief Summary

role of placenta accreta index score in prediction of conservative surgery for placenta placenta accreta spectrum

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

August 21, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 24, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

August 24, 2022

Status Verified

August 1, 2022

Enrollment Period

1.8 years

First QC Date

August 21, 2022

Last Update Submit

August 21, 2022

Conditions

Placenta Accreta, Third Trimester

Outcome Measures

Primary Outcomes (1)

  • Accuracy of PAS index score in prediction of conservative surgery

    2022 to 2024

Secondary Outcomes (1)

  • Intraoperative blood loss

    at delivery

Interventions

placenta accreta index scoreDIAGNOSTIC_TEST

role of placenta accreta index score in prediction of conservative surgery for placenta placenta accreta spectrum

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

• Pregnant women above 28 weeks gestation by 1st trimesteric U/S,2nd trimesteric U/S or sure reliable dates; diagnosed as placenta previa by 2D ultrasound, Doppler on placental bed. Patients who have done one or more cesarean sections

You may qualify if:

  • Pregnant women above 28 weeks gestation by 1st trimesteric U/S,2nd trimesteric U/S or sure reliable dates; diagnosed as placenta previa by 2D ultrasound, Doppler on placental bed.
  • Patients who have done one or more cesarean sections

You may not qualify if:

  • Patients who refuse to participate in our study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ainshams university

Cairo, Egypt

Location

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Officials

  • Ahmed M Mamdouh

    Ainshams university

    STUDY DIRECTOR

Central Study Contacts

sahar M abdelmaksoud, masters

CONTACT

01110065637saharabdelmaksoud@yahoo.com

Amr S mahmoud

CONTACT

+201010051381

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2022

First Posted

August 24, 2022

Study Start

August 1, 2022

Primary Completion

June 1, 2024

Study Completion

July 1, 2024

Last Updated

August 24, 2022

Record last verified: 2022-08

Locations

EG(1)